Alterations of uromodulin biology: a common denominator of the genetically heterogeneous FJHN/MCKD syndrome

. 2006 Sep ; 70 (6) : 1155-69. [epub] 20060802

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid16883323

Odkazy
PubMed 16883323
DOI 10.1038/sj.ki.5001728
PII: S0085-2538(15)52076-0
Knihovny.cz E-zdroje

Autosomal dominant hyperuricemia, gout, renal cysts, and progressive renal insufficiency are hallmarks of a disease complex comprising familial juvenile hyperuricemic nephropathy and medullary cystic kidney diseases type 1 and type 2. In some families the disease is associated with mutations of the gene coding for uromodulin, but the link between the genetic heterogeneity and mechanism(s) leading to the common phenotype symptoms is not clear. In 19 families, we investigated relevant biochemical parameters, performed linkage analysis to known disease loci, sequenced uromodulin gene, expressed and characterized mutant uromodulin proteins, and performed immunohistochemical and electronoptical investigation in kidney tissues. We proved genetic heterogeneity of the disease. Uromodulin mutations were identified in six families. Expressed, mutant proteins showed distinct glycosylation patterns, impaired intracellular trafficking, and decreased ability to be exposed on the plasma membrane, which corresponded with the observations in the patient's kidney tissue. We found a reduction in urinary uromodulin excretion as a common feature shared by almost all of the families. This was associated with case-specific differences in the uromodulin immunohistochemical staining patterns in kidney. Our results suggest that various genetic defects interfere with uromodulin biology, which could lead to the development of the common disease phenotype. 'Uromodulin-associated kidney diseases' may be thus a more appropriate term for this syndrome.

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

A Novel Monoallelic ALG5 Variant Causing Late-Onset ADPKD and Tubulointerstitial Fibrosis

. 2024 Jul ; 9 (7) : 2209-2226. [epub] 20240415

Autosomal dominant tubulointerstitial kidney disease: A review

. 2022 Sep ; 190 (3) : 309-324. [epub] 20221017

Autosomal dominant tubulointerstitial kidney disease: more than just HNF1β

. 2022 May ; 37 (5) : 933-946. [epub] 20210522

Phenylbutyrate rescues the transport defect of the Sec61α mutations V67G and T185A for renin

. 2022 Apr ; 5 (4) : . [epub] 20220121

Ultrabright plasmonic fluor nanolabel-enabled detection of a urinary ER stress biomarker in autosomal dominant tubulointerstitial kidney disease

. 2021 Aug 01 ; 321 (2) : F236-F244. [epub] 20210712

Genetic and Clinical Predictors of Age of ESKD in Individuals With Autosomal Dominant Tubulointerstitial Kidney Disease Due to UMOD Mutations

. 2020 Sep ; 5 (9) : 1472-1485. [epub] 20200703

Autosomal dominant tubulointerstitial kidney disease-UMOD is the most frequent non polycystic genetic kidney disease

. 2018 Oct 30 ; 19 (1) : 301. [epub] 20181030

Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease

. 2018 Sep ; 29 (9) : 2418-2431. [epub] 20180702

Elevated urinary CRELD2 is associated with endoplasmic reticulum stress-mediated kidney disease

. 2017 Dec 07 ; 2 (23) : . [epub] 20171207

Autosomal Dominant Tubulointerstitial Kidney Disease

. 2017 Mar ; 24 (2) : 86-93.

Heterozygous Loss-of-Function SEC61A1 Mutations Cause Autosomal-Dominant Tubulo-Interstitial and Glomerulocystic Kidney Disease with Anemia

. 2016 Jul 07 ; 99 (1) : 174-87.

Tamm Horsfall Glycoprotein and Uromodulin: It Is All about the Tubules!

. 2016 Jan 07 ; 11 (1) : 6-8. [epub] 20151218

Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure

. 2009 Aug ; 85 (2) : 204-13. [epub] 20090806

Abnormal expression and processing of uromodulin in Fabry disease reflects tubular cell storage alteration and is reversible by enzyme replacement therapy

. 2008 Aug ; 31 (4) : 508-17. [epub] 20080727

Najít záznam

Citační ukazatele

Nahrávání dat...

Možnosti archivace

Nahrávání dat...